(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RENMICE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

RENMICE

ST13

US500000079975694

Class

31, 42

Filing

79975694

Registration

7123569

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

12/18/2023

Trademark type

Word

Nice classes

31, 42

Filing date

10/20/2021

Registration date

08/01/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/01/2023

Last transaction

08/01/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

CN

Examiner

KEAM, ALEX S

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Representatives

Karen Feisthamel KDB Firm PLLC

Technical classification

Nice Classes

Class 31Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 31

Live trees; live plants; hamsterslive; live animals; poultrylive; live laboratory animals; live menagerie animalsmice; plant seeds; fodder; litter for animals

Class 42

Technological researchpharmaceutical research; development of products for others; research and development of new products for others; quality control inspection in the field of pharmaceutical research and development; biochemical research and analysis; biological research; Medical and scientific researchconducting clinical trials for others; research and development of antibodies; development of pharmaceutical preparations and medicines; pharmaceutical development services; pharmaceutical research and development; pharmaceutical testing; packaging design; architectural design; computer programming; research in the field of artificial intelligence; computer programming in medical care; conversion of data or documents from physical to electronic media

Publications

History of USPTO decisions and trademark events.

36 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

12/18/2023

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

11/02/2023

XXCR

GENERIC MADRID TRANSACTION CREATED

11/02/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/01/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/01/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

08/01/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

06/12/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/24/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

05/24/2023

GPNX

NOTIFICATION PROCESSED BY IB

05/17/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/16/2023

PUBO

PUBLISHED FOR OPPOSITION

05/16/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/26/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/26/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/26/2023

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

04/10/2023

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

04/07/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/01/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

03/28/2023

MNDA

NOTICE OF DIVIDED TRADEMARK APPLICATION MAILED

03/28/2023

DPCC

DIVISIONAL PROCESSING COMPLETE

03/23/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/23/2023

DRRR

DIVISIONAL REQUEST RECEIVED

03/01/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/01/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/01/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/01/2023

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

03/01/2023

RFNT

REFUSAL PROCESSED BY IB

09/27/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/03/2022

RFRR

REFUSAL PROCESSED BY MPU

09/03/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

08/01/2022

CNRT

NON-FINAL ACTION WRITTEN

07/31/2022

DOCK

ASSIGNED TO EXAMINER

07/27/2022

MAFR

APPLICATION FILING RECEIPT MAILED

01/07/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/03/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/23/2021

Continuous trademark protection

Get notified about every new filing that threatens RENMICE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.